rss
Br J Ophthalmol 2009;93:891-894 doi:10.1136/bjo.2007.129981
  • Clinical science
    • Original Article

Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation

  1. M P Y Chan1,
  2. J L Hungerford1,
  3. J E Kingston2,
  4. P N Plowman3
  1. 1
    Ocular Oncology Service, St Bartholomew’s and The Royal London Hospitals, London, UK
  2. 2
    Department of Paediatric Oncology, St Bartholomew’s and The Royal London Hospitals, London, UK
  3. 3
    Department of Clinical Oncology, St Bartholomew’s and The Royal London Hospitals, London, UK
  1. Mr J L Hungerford, Ocular Oncology Service, St Bartholomew’s Hospital, London EC1A 7BE, UK; john.hungerford{at}btopenworld.com
  • Accepted 20 December 2008
  • Published Online First 26 March 2009

Abstract

Background: Radiation is implicated in the induction of second malignancies in children with bilateral retinoblastoma. There is a need to determine whether this risk can be justified by good visual outcome when external beam radiotherapy (EBRT) is used as a salvage treatment.

Aim: To study the effectiveness of EBRT as a salvage treatment after failed primary chemotherapy and focal treatment in bilateral retinoblastoma.

Methods: This is a retrospective observational case series. The outcome measures after EBRT are: rate of eye preservation, rate of tumour control, visual potential, visual acuity and radiation-induced side-effects.

Results: Thirty-six eyes (22 patients) were included. The median follow-up after EBRT was 40 months (19–165 months). Thirty-two eyes received lens-sparing radiotherapy, and four received whole-eye radiation. The rate of eye preservation was 83.3% (30/36 eyes). Twenty-four eyes (66.7%) were controlled by EBRT and required no further treatment. Of the 30 preserved eyes, 20 eyes (66.7%) had extramacular tumours without retinal detachment and therefore potential for central vision. The final visual acuity was recorded for 19 eyes. Ten eyes (52.6%) read 6/9–6/5, three eyes (15.8%) read 6/18–6/36, and six eyes (31.6%) read 6/60 or worse. Significant radiation- induced side effects were limited to cataracts and dry eyes with whole-eye radiation. There were no second cancers or deaths.

Conclusion: Salvage EBRT is highly effective in preserving eyes with useful vision in bilateral retinoblastoma after failed chemotherapy and focal treatments. These results will help the parents and ophthalmologists of such patients to reach an informed decision when weighing up the benefits of EBRT against its potential oncogenic effect.

Footnotes

  • Competing interests: None.

  • See Editorial, p 848

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. bjo.2007.129981v1
    2. 93/7/891 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.